South China Morning Post (CN)
Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital
Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a…